Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up

被引：0
|
作者：
M Isaac
N Tehrani
K Mireskandari
机构：
[1] The Hospital for Sick Children,Department of Ophthalmology and Vision Sciences
[2] University of Toronto,Department of Ophthalmology and Vision Sciences
来源：
Eye | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 341
页数：8
相关论文
共 50 条
  • [41] Angiographic review of Choroidal Involution in eyes with Retinopathy of Prematurity post Bevacizumab treatment
    Andersen, Lorick
    Islam, Yasmin
    Agarwal-Sinha, Swati
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [42] Comparison of Intravitreal Ranibizumab and Laser Photocoagulation in the Treatment of Type I Retinopathy of Prematurity in Malaysia: A OneYear Follow-Up Study
    Wardati, H. Jami
    Khadijah, Mustafa
    Nurul-Farhana, Mustafa
    Karimmah, Wahit
    Lai, Yoon Kit Ivan
    Syahmi, Md Razali
    Chew, Fiona Lee Min
    Rahmat, Jamalia
    Hamzah, Norhafizah
    Shatriah, Ismail
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [43] Regression patterns of Retinopathy of Prematurity after intravitreal injection of Ranibizumab
    Ji, Marco H.
    Moshfeghi, Darius
    Shields, Ryan A.
    Bodnar, Zachary
    Ludwig, Cassie A.
    Callaway, Natalia F.
    Leng, Theodore
    Sanislo, Steven
    Orazi, Lorenzo
    Amorelli, Giulia
    Lepore, Domenico
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [44] Bevacizumab and Angiogenesis Factors Levels in the Vitreous of Recurrent Retinopathy of Prematurity after Intravitreal Injection of Bevacizumab
    Kong, Lingkun
    Chang, Emmanuel
    Demny, Ann B.
    Devaraj, Sridevi
    Stout, Tim
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [45] INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY AND EXACERBATION OF PULMONARY HYPERTENSION
    Park, L.
    Donohue, L.
    Lakshminrusimha, S.
    Sankaran, D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (04) : 1109 - 1110
  • [46] Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
    Obata, Shumpei
    Ichiyama, Yusuke
    Matsumoto, Riko
    Kakinoki, Masashi
    Saishin, Yoshitsugu
    Yanagi, Takahide
    Maruo, Yoshihiro
    Ohji, Masahito
    PLOS ONE, 2021, 16 (12):
  • [47] Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension
    Park, Lidia
    Donohue, Lee
    Lakshminrusimha, Satyan
    Sankaran, Deepika
    JOURNAL OF PERINATOLOGY, 2023, 43 (02) : 236 - 237
  • [48] Hypertension in neonates treated with intravitreal bevacizumab for retinopathy of prematurity
    Twitty, Grace
    Weiss, Michael
    Bazacliu, Catalina
    O'Mara, Keliana
    Mowitz, Meredith E.
    JOURNAL OF PERINATOLOGY, 2021, 41 (06) : 1426 - 1431
  • [49] What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
    Kim, Hoon Dong
    Kim, Seung Hoon
    Cho, In Hwan
    Moon, Chan Hee
    Ohn, Young-Hoon
    Park, Tae Kwann
    ACTA OPHTHALMOLOGICA, 2013, 91 (02) : e154 - e156
  • [50] Intravitreal low-dosage bevacizumab for retinopathy of prematurity
    Harder, Bjoern C.
    von Baltz, Stefan
    Jonas, Jost B.
    Schlichtenbrede, Frank C.
    ACTA OPHTHALMOLOGICA, 2014, 92 (06) : 577 - 581
12345